Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective

Jones, HM, Chen, Y, Gibson, C, Heimbach, T, Parrott, N, Peters, SA, Snoeys, J, Upreti, VV +2 more·2015·Clinical Pharmacology & Therapeutics
DOI 10.1002/cpt.37

Cited by (487)

Items 301–400 of 487

  1. Translational aspects of cytochrome P450‐mediated drug–drug interactions: A case study with clopidogrel
    Aleksi Tornio, Anne M. Filppula, Janne T. Backman · 2021 · Basic & Clinical Pharmacology & Toxicology
  2. Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing
    Alberto Giaretta, Giovanna Petrucci, Bianca Rocca, GIANNA MARIA TOFFOLO · 2022 · PLoS ONE
  3. Managing Innovation to Maximize Value Along the Discovery‐Translation‐Application Continuum
    Scott Arthur Waldman, André Terzic · 2016 · Clinical Pharmacology & Therapeutics
  4. Intra‐Target Microdosing (ITM): A Novel Drug Development Approach Aimed at Enabling Safer and Earlier Translation of Biological Insights Into Human Testing
    Tal Burt, Robert Joseph Noveck, DB Macleod, AT Layton, Malcolm Rowland, Graham Lappin · 2017 · Clinical and Translational Science
  5. Physiologically Based Pharmacokinetic Modeling and Tissue Distribution Characteristics of SHetA2 in Tumor-Bearing Mice
    Ankur Sharma, Mengjie Li, Elangovan Thavathiru, Mariam Ibrahim, Lucila Garcia‐Contreras, Doris M. Benbrook, Sukyung Woo · 2020 · The AAPS Journal
  6. Enzyme-mediated drug-drug interactions: a review of in vivo and in vitro methodologies, regulatory guidance, and translation to the clinic
    Jaydeep Yadav, Benjamin J. Maldonato, Joseph M. Roesner, Ana Gabriela Vergara, Erickson Mesina Paragas, Theresa Aliwarga, Sara C. Humphreys · 2024 · Drug Metabolism Reviews
  7. Model-informed drug discovery and development approaches to inform clinical trial design and regulatory decisions: A primer for the MENA region
    Mohammed S. Alasmari, Salwa Albusaysi, Marwa Elsaeed Elhefnawy, Ali Mohamed Ali, Khalid Altigani, Mohammed Almoslem, Mohammed Alharbi, Jahad Alghamdi, Abdullah Alsultan · 2024 · Saudi Pharmaceutical Journal
  8. Physiologically based pharmacokinetic modeling of midostaurin and metabolites at steady-state to bridge drug interaction scenarios in lieu of clinical trials
    Helen Gu, Romain Séchaud, Imad H. Hanna, Ryan M. Pelis, Heidi J. Einolf · 2025 · Drug Metabolism and Disposition
  9. Therapeutic Cancer Vaccines in Colorectal Cancer: Platforms, Mechanisms, and Combinations
    Chiara Gallio, Luca Esposito, Alessandro Passardi · 2025 · Cancers
  10. Physiologically-based pharmacokinetic modelling in sepsis: A tool to elucidate how pathophysiology affects meropenem pharmacokinetics
    Salma M. Bahnasawy, Neil John Parrott, Matthias Gijsen, Isabel Spriet, Lena E. Friberg, Elisabet I. Nielsen · 2024 · International Journal of Antimicrobial Agents
  11. Development of a Physiologically Based Pharmacokinetic Model for Prediction of Ethanol Concentration-Time Profile in Different Organs
    Armin Sadighi, Lorenzo Leggio, Fatemeh Akhlaghi · 2020 · Alcohol and Alcoholism
  12. Noncompartmental and compartmental approaches to pharmacokinetic data analysis
    David M. Foster, Paolo Vicini · 2021 · Elsevier eBooks
  13. Process Improvement for Maximized Therapeutic Innovation Outcome
    Scott Arthur Waldman, André Terzic · 2017 · Clinical Pharmacology & Therapeutics
  14. A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K+-competitive acid blocker
    Hyun A. Lee, Kyeong‐Ryoon Lee, Seong Bok Jang, Soo Yong Chung, Kyung‐Sang Yu, Howard Lee · 2019 · European Journal of Pharmaceutical Sciences
  15. Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug‐Drug Interaction for Fesoterodine When Coadministered With Mirabegron
    Jian Lin, Theunis C. Goosen, Susanna Y.H. Tse, Hidetomi Yamagami, Bimal K Malhotra · 2019 · The Journal of Clinical Pharmacology
  16. WB‐PBPK approach in predicting zidovudine pharmacokinetics in preterm neonates
    Liuya Wei, Najia Mansoor, Rafeeq Alam Khan, Martin J. Czejka, Tasneem Ahmad, Mansoor Ahmed, Mohsin Ali, Dong‐Hua Yang · 2019 · Biopharmaceutics & Drug Disposition
  17. Oral Drug Delivery, Absorption and Bioavailability
    David Dahlgren, Hans Lennernäs · 2021 · Elsevier eBooks
  18. Physiologically Based Pharmacokinetic Modeling of Lacosamide in Patients With Hepatic and Renal Impairment and Pediatric Populations to Support Pediatric Dosing Optimization
    Xinyu Zhu, Lingfeng Guo, Lei Zhang, Yichao Xu · 2024 · Clinical Therapeutics
  19. Precision, Prediction and Progress: A New Era in Pharmacology
    J. P. Singh, Vinayak Gaur, Preeti Dubey · 2025
  20. Physiologically Based Pharmacokinetic Modeling and Simulations in Lieu of Clinical Pharmacology Studies to Support the New Drug Application of Asciminib
    Ioannis Loisios-Konstantinidis, Felix Huth, Matthias Hoch, Heidi J. Einolf · 2025 · Pharmaceutics
  21. Physiologically based pharmacokinetic modeling in obesity: applications and challenges
    Ruwei Yang, Qin Ding, Junjie Ding, Liyong Zhu, Qi Pei · 2024 · Expert Opinion on Drug Metabolism & Toxicology
  22. Evaluation of BCRP-Related DDIs Between Methotrexate and Cyclosporin A Using Physiologically Based Pharmacokinetic Modelling
    Stephan Schaller, Ingrid N. Michon, Vanessa Baier, Frederico Severino Martins, Patrick Nolain, Amit Taneja · 2024 · Drugs in R&D
  23. Silver Diamine Fluoride in Children Using Physiologically Based PK Modeling
    Kuan‐Fu Chen, Peter Milgrom, Yvonne S. Lin · 2020 · Journal of Dental Research
  24. Performance Evaluation of Montelukast Pediatric Formulations: Part I—Age-Related In Vitro Conditions
    Mariana Guimarães, Pascal Somville, Maria Vertzoni, Nikoletta Fotaki · 2022 · The AAPS Journal
  25. Characterisation of intravenous pharmacokinetics in Göttingen minipig and clearance prediction using established in vitro to in vivo extrapolation methodologies
    Kristine Langthaler, Christopher R. Jones, Rasmus B. Christensen, Elin Eneberg, Birger Brodin, Christoffer Bundgaard · 2022 · Xenobiotica
  26. Physiologically based pharmacokinetic-pharmacodynamic evaluation of meropenem in CKD and hemodialysis individuals
    Guoliang Deng, Fan Yang, Ning Sun, Danhong Liang, Anfen Cen, Chen Zhang, Suiqin Ni · 2023 · Frontiers in Pharmacology
  27. Circulating Biomarkers Instead of Genotyping to Establish Metabolizer Phenotypes
    Roman Tremmel, Ute Hofmann, Mathias Haag, Elke Schaeffeler, Matthias Georg Schwab · 2023 · The Annual Review of Pharmacology and Toxicology
  28. Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab
    Marie‐Emilie Willemin, Shun Xin Wang Lin, Loeckie De Zwart, Liviawati Sutjandra Wu, Xin Miao, Raluca I. Verona, Arnob Banerjee, Baolian Liu, Rachel Kobos, Ming Qi et al. · 2024 · CPT Pharmacometrics & Systems Pharmacology
  29. Drug-drug interactions
    Aleksandra Galetin, Lei Zhang, A. David Rodrigues, Shiew Mei Huang · 2021 · Elsevier eBooks
  30. Regulatory framework on bioequivalence criteria for locally acting gastrointestinal drugs: the case for oral modified release mesalamine formulations
    Gianluca Sferrazza, P.D. Siviero, Giuseppe Nicotera, Paola Turella, Annalucia Serafino, Corrado Blandizzi, Pasquale Pierimarchi · 2017 · Expert Review of Clinical Pharmacology
  31. Novel approaches to address challenges in global drug development
    Beth P Smith, Huang Sm · 2015 · Clinical Pharmacology & Therapeutics
  32. Prediction method of pharmacokinetic parameters of small molecule drugs based on GCN network model
    Zhihua Yang, Ying Wang, Getao Du, Yonghua Zhan, Wenhua Zhan · 2024 · Journal of Molecular Modeling
  33. Evaluation of Solubility-Limited Absorption as a Surrogate to Predicting Positive Food Effect of BCS II/IV Drugs
    Karine Rodríguez-Fernández, José David Gómez‐Mantilla, Suneet Shukla, Peter Stopfer, Peter Sieger, Víctor Mangas‐Sanjuan, Sheila Annie Peters · 2025 · Clinical Pharmacokinetics
  34. Next Generation Risk Assessment of the Anti-Androgen Flutamide Including the Contribution of Its Active Metabolite Hydroxyflutamide
    Tessa C.A. van Tongeren, Paul Lawford Carmichael, Ivonne M.C.M. Rietjens, Hequn Li · 2022 · Frontiers in Toxicology
  35. Physiologically Based Pharmacokinetic Models Can Be Used to Predict the Unique Nonlinear Absorption Profiles of Vismodegib
    Louis Lin, Matthew R. Wright, Cornelis E. C. A. Hop, Harvey Wong · 2022 · Drug Metabolism and Disposition
  36. IDoser: Improving individualized dosing policies with clinical practice and machine learning
    Núria Correa, Jesús Cerquides, Rita Vassena, Mina Popovic, Josep Lluís Arcos · 2023 · Expert Systems with Applications
  37. Physiologically Based Pharmacokinetic Modeling to Unravel the Drug-gene Interactions of Venlafaxine: Based on Activity Score-dependent Metabolism by CYP2D6 and CYP2C19 Polymorphisms
    Chaozhuang Shen, Hongyi Yang, Wenxin Shao, Liang Zheng, Wei Zhang, Haitang Xie, Xuehua Jiang, Ling Wang · 2024 · Pharmaceutical Research
  38. Challenging the status quo: a framework for mechanistic and human-relevant cardiovascular safety screening
    Brian R. Berridge, Jennifer Beck Pierson, Syril D. Pettit, Norman Stockbridge · 2024 · Frontiers in Toxicology
  39. Predicting drug–drug interactions in breast cancer patients treated with CDK4/6 inhibitors and forward planning
    Abha Kulkarni, Jasmeet Chadha Singh · 2024 · Expert Opinion on Drug Metabolism & Toxicology
  40. Clinical Exposure Boost Predictions by Integrating Cytochrome P450 3A4–Humanized Mouse Studies With PBPK Modeling
    Jin Zhang, Tycho Heimbach, Nico Scheer, Avantika Barve, Wenkui Li, Wen Lin, Handan He · 2016 · Journal of Pharmaceutical Sciences
  41. The pharmaceutical industry needs more clinical pharmacologists
    Richard Peck · 2017 · British Journal of Clinical Pharmacology
  42. Cardiovascular Drugs: an Insight of In Silico Drug Design Tools
    Himangshu Sarma, Mohan Upadhyaya, Bitu Gogoi, Mayuri Phukan, Pallabi Kashyap, Bhanita Das, Rajlakshmi Devi, Hemanta Kumar Sharma · 2021 · Journal of Pharmaceutical Innovation
  43. Application of physiologically based pharmacokinetic models to promote the development of veterinary drugs with high efficacy and safety
    Kaixiang Zhou, Kun Mi, Wenjin Ma, Xiangyue Xu, Meixia Huo, Samah Attia Algharib, Yuanhu Pan, Shuyu Xie, Lingli Huang · 2021 · Journal of Veterinary Pharmacology and Therapeutics
  44. Pharmacodynamic Drug–Drug Interactions
    Ming Zheng · 2020 · Springer eBooks
  45. Efficient drug development of oseltamivir capsules based on process control, bioequivalence and PBPK modeling
    Juliana Johansson Soares Medeiros, Thiago M. Costa, Mariana Pereira do Carmo, Diogo Dibo do Nascimento, Eduardo N. C. Lauro, Camila Areias de Oliveira, Marcelo Dutra Duque, Livia Deris Prado · 2022 · Drug Development and Industrial Pharmacy
  46. A Novel Perspective on Using Artificial Intelligence and Nanoinformatics to Develop Nanomedicines
    Nandita Tyagi, Sneha Singh, Seema Dagar, Satyender Kumar, Ashwini Kumar Mishra, Hitesh Kumar Dewangan · 2026 · Current Topics in Medicinal Chemistry
  47. Potential drug-drug interaction of olverembatinib (HQP1351) using physiologically based pharmacokinetic models
    Zhiheng Yu, Zihan Lei, Xueting Yao, Hengbang Wang, Miao Zhang, Zhe Hou, Yafen Li, Yangyu Zhao, Haiyan Li, Dongyang Liu et al. · 2022 · Frontiers in Pharmacology
  48. Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics
    Keyur R. Parmar, Pradeep B. Lukka, Santosh Wagh, Zaid H. Temrikar, Jiuyu Liu, Richard E. Lee Jr., Miriam Braunstein, Anthony James Hickey, Gregory T. Robertson, Mercedes Gonzalez Juarrero et al. · 2023 · Pharmaceutics
  49. The Effect of Legal Uncertainties on the Pharmaceutical Industry
    Amanda Cole-Heath, Pavani Sagiraju · 2024 · Interdisciplinary Studies in Society, Law, and Politics
  50. Physiologically Based Pharmacokinetic Modeling to Assess Ritonavir-Digoxin Interactions and Recommendations for Co-Administration Regimens
    Youjun Chen, Wenxin Shao, Xingwen Wang, Kuo Geng, Wenhui Wang, Yiming Li, Zhiwei Liu, Haitang Xie · 2024 · Pharmaceutical Research
  51. Predictive Biopharmaceutics and Pharmacokinetics
    Yuching Yang, Yang Zhao, John Z. Duan, Ping Zhao, Liang Yu Zhao, X. Zhang · 2017 · Elsevier eBooks
  52. Drug Disposition Considerations in Pharmaceutical Product
    Rahul Maheshwari, Piyoosh A. Sharma, Ankit Seth, Neha Taneja, Muktika Tekade, Rakesh Kumar Tekade · 2018 · Elsevier eBooks
  53. Utility of Physiologically Based Pharmacokinetic Modeling in Point-of-Care Decisions: An Example Using Digoxin Dosing in Continuous Venovenous Hemodiafiltration
    Meenakshi Srinivasan, Raiz Hirani, Melissa Tsiu, Khadija Kabani, Ayyappa Chaturvedula, Brittany N. Palasik · 2019 · Therapeutic Drug Monitoring
  54. Prediction of Transporter-Mediated Drug-Drug Interactions and Phenotyping of Hepatobiliary Transporters Involved in the Clearance of E7766, a Novel Macrocycle-Bridged Dinucleotide
    Rongrong Jiang, Andrew Hart, Laurette Burgess, Dae‐Shik Kim, Weidong G. Lai, Vaishali S. Dixit · 2020 · Drug Metabolism and Disposition
  55. Investigating the Utility of Humanized Pregnane X Receptor-Constitutive Androstane Receptor-CYP3A4/7 Mouse Model to Assess CYP3A-Mediated Induction
    Justin Q. Ly, Susan Wong, Liling Liu, Ruina Li, Kirsten Messick, Jae Hoon Chang · 2021 · Drug Metabolism and Disposition
  56. The Effect of Inflammatory Bowel Disease and Irritable Bowel Syndrome on Pravastatin Oral Bioavailability: In vivo and in silico evaluation using bottom-up wbPBPK modeling
    Mo’tasem M. Alsmadi, Alla A. Abudaqqa, Nasir Idkaidek, Nidal Adel Qinna, Ahmad Al‐Ghazawi · 2024 · AAPS PharmSciTech
  57. Evaluation of Drug–Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model
    Marie‐Emilie Willemin, Jue Gong, Brandi W. Hilder, Tara J. Masterson, Jaszianne A. Tolbert, Thomas M. Renaud, Christoph Johann Heuck, Colleen M. Kane, Loeckie De Zwart, Suzette Girgis et al. · 2024 · Targeted Oncology
  58. Humans Vary, So Cardiac Models Should Account for That Too!
    Barbara Wiśniowska, Zofia Tylutki, Sebastian Polak · 2017 · Frontiers in Physiology
  59. Evaluation of Assumptions Underpinning Pharmacometric Models
    Qing Xi Ooi, Daniel F. B. Wright, Geoffrey Kennedy Isbister, Stephen Brent Duffull · 2019 · The AAPS Journal
  60. Análise farmacocinética, toxicológica e farmacodinâmica in silico do flavonoide quercetina isolado das sementes de Bixa orellana l.
    Maria Camila Leal de Moura, Verônica Lorrânny Lima Araújo, Joubert Aires de Sousa · 2020 · Research Society and Development
  61. A Novel Experimental and Theoretical Method for Estimating Albumin-Mediated Hepatic Uptake Based on the Albumin Binding Fraction in Plasma and Human PK Prediction Using a Physiologically-Based Pharmacokinetic Approach
    Yu Egashira, Tomoka Shimada, Kei Mayumi · 2021 · Journal of Pharmaceutical Sciences
  62. Tissue Distribution and Pharmacokinetic Characteristics of Aztreonam Based on Multi-Species PBPK Model
    Xiao Ye, Xiaolong Sun, Jianing Zhang, Min Yu, Nie Wen, Xingchao Geng, Ying Liu · 2025 · Pharmaceutics
  63. Drug–Drug Interactions and Combination Therapy Strategies of Amiodarone With Digoxin, Rivaroxaban, and Phenytoin Assessed by Physiologically Based Pharmacokinetic Modeling
    Youjun Chen, Zhiwei Liu, Yiming Li, Wenhui Wang, T.K. Chen, Saiya Li, Yating Wu, Haitang Xie · 2025 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
  64. Tiered approaches for screening and prioritizing chemicals through integration of pharmacokinetics and exposure information with in vitro dose-response data
    Jeremy A. Leonard, Yu‐Mei Tan · 2019 · Computational Toxicology
  65. The science of pharmacokinetics: an overview and applications
    Islam M. Ghazi, Michael J. Cawley · 2020 · Elsevier eBooks
  66. Physiologically based pharmacokinetic modeling of CYP2C8 substrate rosiglitazone and its metabolite to predict metabolic drug-drug interaction
    Nilesh Gaud, Dawid Gogola, Anna Kowal-Chwast, Ewelina Gabor-Worwa, Peter Littlewood, Krzysztof D. Brzózka, Kamil Kuś, Maria Walczak · 2024 · Drug Metabolism and Pharmacokinetics
  67. Accelerating Biologics PBPK Modelling with Automated Model Building: A Tutorial
    Abdallah Derbalah, Tariq Abdulla, Maïlys De Sousa Mendes, Qier Wu, Felix Stader, Masoud Jamei, Iain B. Gardner, Armin Sepp · 2025 · Pharmaceutics
  68. [Population pharmacokinetics and its application in new drug research].
    Wenjun Chen, Tianyan Zhou, Wei Lu · 2017 · PubMed
  69. Applications of Physiologically Based Pharmacokinetic (PBPK) Models for Pediatric Populations
    Peng Duan, Jeffrey W. Fisher, Jian Wang · 2016 · Springer eBooks
  70. PREDIÇÃO DO METABOLISMO DO CANDIDATO A FÁRMACO CINAMALDEÍDO: Uma abordagem in silico
    Ítallo Patrick Sousa Amorim, Edgar Ramos Pestana, Saulo José Figueiredo Mendes · 2017 · Revista Ceuma Perspectivas
  71. 3D printing combined with biopredictive dissolution and PBPK/PD modeling optimization and personalization of pharmacotherapy: Are we there yet?
    Gabriela Wyszogrodzka, Olha Shuklinova, Bartek Lisowski, Barbara Wiśniowska, Sebastian Polak · 2023 · Drug Discovery Today
  72. Physiologically Based Pharmacokinetic (PBPK) Modeling: Model Development and Evaluation
    Manuel Ibarra, Alejandra Schiavo, Lawrence J. Lesko · 2022 · Springer eBooks
  73. Population Modelling
    Dimple Patil, Jagannath Sahoo, Rohan V. Pai, S. N. Koteswara Rao G. · 2025 · Springer eBooks
  74. Precision dosing of perampanel in pediatric patients receiving oxcarbazepine combination therapy: physiologically based pharmacokinetic modeling and simulation
    Si-Ting Liu, Chengjie Ke, Jing Su, Yu-Die Qian, Wan-Hong Wu, Xi Lin, Wei-Wei Lin · 2025 · Expert Review of Clinical Pharmacology
  75. The predictive edge: modeling and simulation in drug product development
    Sanjay Konagurthu, Dineli T. S. Ranathunga, Stephanie Buchanan, Nairuti Milan Mehta, Tom Reynolds · 2026 · Advanced Drug Delivery Reviews
  76. Impact of Preclinical Verification in Physiologically Based Pharmacokinetic Modelling for First-in-Human Predictions: Application of a Published Model Building Strategy for Five Compounds
    Claire Jackson, Rebecca H. Graves, Thuy T. Tran, Neil A. Miller · 2026 · Clinical Pharmacokinetics
  77. The role of drug metabolism in drug discovery and development : case ospemifene
    Jouko Uusitalo · 2015
  78. Precision drug dosing: A major opportunity for patients and pharmacists
    Natalie F. Pearce, Erika M. Giblin, Catherine Buckthal, Alana Ferrari, J. Robert Powell, Yanguang Cao, James Herbert Patterson · 2018 · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
  79. Computational approaches for drug-metabolizing enzymes: Concepts and challenges
    Usman Ali Ashfaq, Farah Shahid, Samman Munir · 2022 · Elsevier eBooks
  80. Incubation Time Influences Organic Anion Transporter 1 Kinetics and Renal Clearance Predictions
    Aaron O. Buaben, Ryan M. Pelis · 2023 · Journal of Xenobiotics
  81. Applying quantitative and systems pharmacology to drug development and beyond: An introduction to clinical pharmacologists
    Mathan Kumar Ramasubbu, Bhairav Suryakant Paleja, Anand Srinivasann, Rituparna Maiti, Rukmini Kumar · 2024 · Indian Journal of Pharmacology
  82. Model-Based Dose Selection of a Sphingosine-1-Phosphate Modulator, Etrasimod, in Patients with Various Degrees of Hepatic Impairment
    Mohammed S. Alasmari, Faleh Alqahtani, Fawaz F. Alasmari, Abdullah Alsultan · 2024 · Pharmaceutics
  83. Solubility-Limited Absorption Identified by a Simplified PBPK Model for the Prediction of Positive Food Effect for BCS II/IV Drugs
    Karine Rodríguez-Fernández, José David Gómez‐Mantilla, Suneet Shukla, Víctor Mangas‐Sanjuan, Sheila Annie Peters · 2025 · Clinical Pharmacokinetics
  84. Opportunities and Challenges of Hepatic Impairment Physiologically Based Pharmacokinetic Modeling in Drug Development—An IQ Perspective
    Hisham Qosa, Islam Rasem Younis, Vaishali Sahasrabudhe, Ashish Sharma, Yan Jin, Gerald R. Galluppi, Maria M. Posada, Jitendra Kanodia · 2025 · Clinical Pharmacology & Therapeutics
  85. Using Physiologically Based Pharmacokinetic Models for Assessing Pharmacokinetic Drug–Drug Interactions in Patients with Chronic Heart Failure Taking Narrow Therapeutic Window Drugs
    Nadezhda Hvarchanova, Maya P. Radeva-Ilieva, Kaloyan Georgiev · 2025 · Pharmaceuticals
  86. Physiologically based pharmacokinetic modelling to predict artemether and lumefantrine exposure in neonates weighing less than 5 kg treated with artemether–lumefantrine to supplement the clinical data from the CALINA study
    Helen Gu, Nada Abla, Vinay Kumar Venishetty, Birgit Schoeberl, Julia Zack, Heidi J. Einolf · 2025 · Tropical Medicine and Health
  87. Characterization of CAR-T cellular kinetics and efficacy in solid tumor patients with and without prior lymphodepletion chemotherapy using a PBPK-PD model
    Keyur R. Parmar, Agnish Dey, Angelia F Wang, Ganesh M. Mugundu, Aman Preet Singh · 2025 · Journal of Pharmacokinetics and Pharmacodynamics
  88. Modeling and simulation of pharmacokinetic drug-drug interaction caused by induction of metabolic enzymes
    Fumiyoshi Yamashita · 2016 · Folia Pharmacologica Japonica
  89. Bottom-up physiologically based pharmacokinetic modelling for predicting the human pharmacokinetic profiles of the ester prodrug MGS0274 and its active metabolite MGS0008, a metabotropic glutamate 2/3 receptor agonist
    Motoki Ochi, Kohnosuke Kinoshita, Junichi Yamaguchi, Hiromi Endo · 2022 · Xenobiotica
  90. Challenges and Opportunities in the Management of Cardiovascular Diseases
    Himangshu Sarma, Jon Jyoti Sahariah, Rajlakhsmi Devi, Hemanta Kumar Sharma · 2022 · Sciences of Phytochemistry
  91. Advancements in physiologically based pharmacokinetic modeling for fedratinib: updating dose guidance in the presence of a dual inhibitor of CYP3A4 and CYP2C19
    Ming Chang, Yizhe Chen, Ken Ogasawara, Brian James Schmidt, Lu Gaohua · 2024 · Cancer Chemotherapy and Pharmacology
  92. Dynamic Simulation of Drug-Drug Interactions by Using Multi-level Physiological Modeling & Simulation Platforms
    Fumiyoshi Yamashita · 2018 · YAKUGAKU ZASSHI
  93. Exploration of sexual dimorphism and inter-individual variability in multivariate parameter spaces for a pharmacokinetic compartment model
    Megerle L. Scherholz, Ioannis P. Androulakis · 2018 · Mathematical Biosciences
  94. The application of computer simulation to investigate drug absorption and bioavailability in disease states
    May Almukainzi · 2015 · ERA: Education and Research Archive (University of Alberta)
  95. REGULATORY GUIDELINES ON THE REPORTING OF PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODELING ANALYSIS
    Sheila Annie Peters · 2021
  96. Editorial: Pharmacokinetic evaluation and modeling of clinically significant drug metabolites, Volume II
    Momir Mikov, Maja Đanić, Slavica Lazarević, Nebojša Pavlović, Bojan Stanimirov, Hani Al‐Salami, Armin Mooranian · 2023 · Frontiers in Pharmacology
  97. Applications of PBPK Modeling and Simulations in The Clinical Pharmacology Field: Lessons from Several Case Studies
    Chie Emoto, Kosuke Doki, Yuki Matsumoto, Shinichi Kijima, Mikiko Nakamura, Tsuyoshi Fukuda · 2020 · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
  98. Prediction of Local Drug Exposure of Dry Powder Inhaler CXG87 (budesonide/formoterol) Using Physiologically‐Based Pharmacokinetic Model
    Yuran Cao, Yuming Hu, Jing Zhang, Bo Liu, Lan Chen, Donghao Chen, Meiqing Feng · 2025 · Clinical Pharmacology & Therapeutics
  99. Predicting drug–drug interactions and optimal dosing of betrixaban with physiologically based pharmacokinetic modeling in patients with renal impairment who were coadministered with P-glycoprotein inhibitors
    Xiaoping Yan, Lirong Xiao, Weina Xie · 2025 · Journal of International Medical Research
  100. Evaluating Pharmacokinetic Models of Iodized Contrast Using Physics-Informed Neural Networks
    T. Souza, R. Amorim, Vinícius de Carvalho Rispoli · 2025 · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany